Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
73.00    1.65 (2.31%)
Bid:
72.70
Ask:
73.20
Spread: 0.50 (0.688%)
Market Cap: £270.95m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Directorate Change

2 Oct 2023 07:00

RNS Number : 2677O
RWS Holdings PLC
02 October 2023
 

 

For immediate release                                                                                                    2 October 2023

 RWS Holdings plc

Update on Board Changes

 

RWS Holdings plc ("RWS" or "the Group"), a unique world-leading provider of technology-enabled language, content and intellectual property services, confirms that Julie Southern has been appointed Independent, Non-executive Chairman, as was anticipated by the announcement on 27 July 2022. Having stepped down as Chairman, Andrew Brode will remain on the Board as a Non-executive Director.

Julie Southern has served as a Non-executive Director and Chairman Designate of RWS as part of the Group's succession planning since July 2022. In her new role, she will also chair the Nomination Committee but will step down from the Group's Audit Committee in line with corporate governance best practice. Julie brings a wealth of business, strategic and governance experience from her current and previous Non-executive Director roles. She is currently Chair of the Board of NXP Semiconductors, where she has been a Non-executive Director since 2013 and is also a Non-executive Director at Ocado Group.

Ian El-Mokadem, Chief Executive Officer of RWS, commented:

"Andrew has been fundamental to RWS's success since leading a buyout in 1995. He has overseen a series of significant milestones, from listing the Group on AIM in 2003 to overseeing tremendous growth in revenues and profits, driven both by the underlying business and a series of acquisitions. Without his dedication to the Group, we would not have achieved our market leading position. The Board, and everyone at RWS, owes Andrew a huge debt of gratitude for his contributions over many years. We look forward to continuing to benefit from his wise counsel as a Non-executive Director.

As we look to the future, we welcome Julie Southern as our Chairman. Her leadership, strategic and governance experience will ensure that we are well positioned to deliver on our medium-to-long term objectives."

For further information, please contact:

RWS Holdings plc

Ian El-Mokadem, Chief Executive Officer

Candida Davies, Chief Financial Officer

 

 

01753 480200

 

MHP (Financial PR Advisor)

Katie Hunt / Eleni Menikou / Catherine Chapman

 

rws@mhpc.com

020 3128 8100

07884 494 112

 

Numis (Nomad & Joint Broker)

Stuart Skinner / Kevin Cruickshank / Will Baunton

 

 

 

020 7260 1000

 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff

 

020 3207 7800

 

About RWS RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

 

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

 

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

 

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

For further information, please visit: www.rws.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFSIIDLLIIV
Date   Source Headline
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20248:20 amRNSHolding(s) in Company
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20249:00 amRNSPublication of Annual Report and Notice of AGM
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSNon-executive Director Resignation
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 202311:20 amRNSAIM Rule 17 Update
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20234:10 pmRNSHolding(s) in Company
21st Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSAppointment of Non-executive Directors
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.